Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Izotropic Corp C.IZO

Alternate Symbol(s):  IZOZF

Izotropic Corporation is a Canada-based medical device company. The Company is engaged in the development and commercialization of IzoView, a computed tomography (CT) imaging system, which produces cross-sectional images that can be imaged in the 30 centi-meter aperture by computer reconstruction of x-ray transmission data for non-invasive visualization of tissue. The IzoView is for use in the non-invasive visualization of breast tissue, as an adjunct tool to mammography, by providing x-ray computer reconstructed images as an aid for qualified healthcare providers. The Company has not generated any revenue.


CSE:IZO - Post by User

Post by gunzodon Dec 01, 2020 4:47pm
452 Views
Post# 32012092

news

news

Amount of Broker Warrant Issued

(TheNewswire)



VANCOUVER, BC - TheNewswire December 1, 2020 - Izotropic Corporation (" Izotropic " or the " Company ") (CSE: IZO (CNSX:IZO.CN) U.S. (OTC: IZOZF ) (FSE: 1R3 ) announces that it has cancelled 600,000 options previously issued to consultants.

Th Company also announces that further to its News Release of October 30, 2020, whereby it announced the closing of a second and final tranche of its non-brokered private placement (the "Offering") of 2,866,334 units (each, a "Unit") at a price of $0.55 per Unit for gross proceeds of $1,576,483.70, it wishes to disclose the updated amount of broker warrants paid in connection with the Offering to 193,995 Broker Warrants.

ON BEHALF OF THE BOARD


Robert Thast

Chief Executive Officer

Investor Relations, Dan Sammartino: 1-778-962-0234
Email: 
info@izocorp.com


<< Previous
Bullboard Posts
Next >>